1. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362: 1733–1745.
2. Russell CA, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science (New York) 2008; 320: 340–346.
3. Stohr K. Influenza – WHO cares. Lancet Infectious Diseases 2002; 2: 517.
4. Flahault A. Global monitoring of influenza: potential contribution of national networks from a French perspective. Expert Review of Anti-infective Therapy 2006; 4: 387–393.
5. Fouchier RA, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. Journal of Virology 2005; 79: 2814–2822.
6. Hampson AW, Mackenzie JS. The influenza viruses. Medical Journal of Australia 2006; 185: S39–43.
7. Nelson MI, et al. Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathogens 2007; 3: 1220–1228.
8. Sampath R, et al. Global surveillance of emerging influenza virus genotypes by mass spectrometry. PLoS ONE 2007; 2: e489.
9. Katz JM, et al. Immunity to influenza: the challenges of protecting an aging population. Immunology Research 2004; 29: 113–124.
10. Williams JR, et al. Influenza: prospect for prevention and control. Kaohsiung Journal of Medical Science 2002; 18: 421–434.
11. Zhang WD, Evans DH. Detection and identification of human influenza viruses by the polymerase chain reaction. Journal of Virological Methods 1991; 33: 165–189.
12. Wright KE, et al. Typing and subtyping of influenza viruses in clinical samples by PCR. Journal of Clinical Microbiology 1995; 33: 1180–1184.
13. Davydov OV. Micromethod for the HI test in the diagnosis of influenza and para-influenza infections [in Russian]. Voprosy Virusologii 1966; 11: 613–616.
14. Pechirra P, et al. Molecular characterization of the HA gene of influenza type B viruses. Journal of Medical Virology 2005; 77: 541–549.
15. Bush RM, et al. Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. Proceedings of the National Academy of Sciences USA 2000; 97: 6974–6980.
16. Fitch WM, et al. Long term trends in the evolution of H(3) HA1 human influenza type A. Proceedings of the National Academy of Sciences USA 1997; 94: 7712–7718.
17. Ciccozzi M, et al. Evolutionary analysis of HA and NS1 genes of H5N1 influenza viruses in 2004–2005 epidemics. Avian diseases 2007; 51: 455–460.
18. Martin V, et al. History and evolution of HPAI viruses in southeast Asia. Annals of the New York Academy of Sciences 2006; 1081: 153–162.
19. Boivin G, et al. Predicting influenza infections during epidemics with use of a clinical case definition. Clinical Infectious Diseases 2000; 31: 1166–1169.
20. Navarro-Mari JM, et al. Influenza-like illness criteria were poorly related to laboratory-confirmed influenza in a sentinel surveillance study. Journal of Clinical Epidemiology 2005; 58: 275–279.
21. Nicholson KG. Clinical features of influenza. Seminars in Respiratory Infections 1992; 7: 26–37.
22. Vong S, et al. Environmental contamination during influenza A virus (H5N1) outbreaks, Cambodia, 2006. Emerging Infectious Diseases 2008; 14: 1303–1305.
23. Kendal AP, Cate TR. Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79. Journal of Clinical Microbiology 1983; 18: 930–934.
24. Tamura K, et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Molecular Biology and Evolution 2007; 24: 1596–1599.
25. Sheu TG, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrobial Agents and Chemotherapy 2008; 52: 3284–3292.
26. McKimm-Breschkin J, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrobial Agents and Chemotherapy 2003; 47: 2264–2272.
27. Bright RA, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005; 366: 1175–1181.
28. Deyde VM, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. Journal of Infectious Diseases 2007; 196: 249–257.
29. Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annual Review of Medicine 2000; 51: 407–421.
30. Finkelman BS, et al. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: Viral coexistence and latitudinal gradients. PLoS ONE 2007; 2: e1296.
31. Viboud C, Alonso WJ, Simonsen L. Influenza in tropical regions. PLoS Medicine 2006; 3: e89.
32. Viboud C, et al. Association of influenza epidemics with global climate variability. European Journal of Epidemiology 2004; 19: 1055–1059.
33. Park AW, Glass K. Dynamic patterns of avian and human influenza in east and southeast Asia. Lancet Infectious Diseases 2007; 7: 543–548.
34. Tang JW, et al. Seasonality of influenza A(H3N2) virus: a Hong Kong perspective (1997–2006). PLoS ONE 2008; 3: e2768.
35. Nguyen HL, et al. Epidemiology of influenza in Hanoi, Vietnam, from 2001 to 2003. Journal of Infection 2007; 55: 58–63.
36. Hsieh YC, et al. Influenza in Taiwan: seasonality and vaccine strain match. Journal of Microbiology, Immunology, and Infection 2005; 38: 238–243.
37. Jian JW, et al. Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003 to 2006. Journal of Clinical Microbiology 2008; 46: 1426–1434.
38. Lin JH, et al. Genetic and antigenic analysis of epidemic influenza viruses isolated during 2006–2007 season in Taiwan. Journal of Medical Virology 2008; 80: 316–322.
39. Shek LP, Lee BW. Epidemiology and seasonality of respiratory tract virus infections in the tropics. Paediatric Respiratory Reviews 2003; 4: 105–111.
40. Doraisingham S, et al. Influenza surveillance in Singapore: 1972–86. Bulletin of the World Health Organization 1988; 66: 57–63.
41. Chew FT, et al. Seasonal trends of viral respiratory tract infections in the tropics. Epidemiology and Infection 1998; 121: 121–128.
42. Claas EC, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998; 351: 472–477.
43. Peiris JS, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363: 617–619.
44. Liang W, et al. Severe acute respiratory syndrome, Beijing, 2003. Emerging Infectious Diseases 2004; 10: 25–31.
45. Buchy P, et al. Influenza A/H5N1 virus infection in humans in Cambodia. Journal of Clinical Virology 2007; 39: 164–168.
46. Brankston G, et al. Transmission of influenza A in human beings. Lancet Infectious Diseases 2007; 7: 257–265.